mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.18 |
0.003 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.005 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.006 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.008 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.008 |